carbidopa/entacapone/levodopa (Stalevo)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Stalevo Contains carbidopa/levodopa & entacapone.

Indications

Dosage

  • one tablet/dose; maximum 8 tablets/day

Tabs: 3 strengths of carbidopa/levodopa

  • 12.5/50, 25/100 37.5/150 (mg/mg)
  • 200 mg of entacapone

Adverse effects

More general terms

Components

References

  1. Prescriber's Letter 10(8):45 2003
  2. Bronstein J, In: Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 29-Oct 2, 2004
  3. 3.0 3.1 FDA Medwatch Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm206934.htm
  4. 4.0 4.1 FDA Medwatch Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm223423.htm
  5. 5.0 5.1 4) FDA Safety Alert. Oct 26, 2015 Entacapone: Drug Safety Communication - FDA Review Found No Increased Cardiovascular Risks. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm469162.htm